2019
DOI: 10.33263/briac101.728733
|View full text |Cite
|
Sign up to set email alerts
|

Formulation and development of hesperidin loaded solid lipid nanoparticles for diabetes

Abstract: Most of the research on Diabetes has been focused on synthetic compound however the disease burden of Diabetes has not been reduced, natural chemistry has provided various safer options in different disease areas. Hesperidin (bioflavonoid) has shown good promise in anti-diabetes efficacy however its bioavailability is low. In this work, SLN of Hesperidin wasprepared, physiochemically evaluated and tested for anti-diabetic potential. Various drug- lipid ratio were tested along with other formulation parameter f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 22 publications
0
2
0
Order By: Relevance
“…The HSP-SLN formulation displayed improved anti-diabetic activity by increasing HSP solubility (Gaur et al, 2020). The use of supercritical antisolvent technology in the synthesis of HSP-SLN carriers further improved their oral bioavailability.…”
Section: Solid Lipid Nanoparticlesmentioning
confidence: 99%
“…The HSP-SLN formulation displayed improved anti-diabetic activity by increasing HSP solubility (Gaur et al, 2020). The use of supercritical antisolvent technology in the synthesis of HSP-SLN carriers further improved their oral bioavailability.…”
Section: Solid Lipid Nanoparticlesmentioning
confidence: 99%
“…Lipid nanoparticles (LNPs) have attracted considerable research interest for encapsulating TNAs, especially due to their ionizable lipid presence, which is cationic at a low pH, thus, allowing complexation with negatively charged RNA or DNA [21,22]. Various generations of lipid nanocarriers have been tackled for TNAs delivery, including liposomes, solid lipid nanoparticles, nanostructured lipid carriers, and cationic lipid-nucleic acid complexes [23].…”
Section: Lipid-based Delivery Systemsmentioning
confidence: 99%